Acadian Asset Management’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,718
Closed -$739K 1871
2023
Q1
$739K Sell
9,718
-3,701
-28% -$298K ﹤0.01% 955
2022
Q4
$1.29M Buy
13,419
+5,961
+80% +$644K 0.01% 780
2022
Q3
$840K Buy
7,458
+5,470
+275% +$636K ﹤0.01% 845
2022
Q2
$251K Buy
+1,988
New +$175K ﹤0.01% 1140
2021
Q3
Sell
-2,112
Closed -$131K 1957
2021
Q2
$131K Sell
2,112
-4,010
-66% -$225K ﹤0.01% 1560
2021
Q1
$452K Buy
6,122
+6,052
+8,646% +$581K ﹤0.01% 1234
2020
Q4
$6K Buy
+70
New +$5.87K ﹤0.01% 2173
2019
Q1
Sell
-1,377
Closed -$43K 2022
2018
Q4
$43K Sell
1,377
-765
-36% -$23.3K ﹤0.01% 1451
2018
Q3
$64K Hold
2,142
﹤0.01% 1310
2018
Q2
$70K Buy
2,142
+293
+16% +$9.69K ﹤0.01% 1331
2018
Q1
$55K Buy
1,849
+472
+34% +$12K ﹤0.01% 1338
2017
Q4
$30K Buy
1,377
+355
+35% +$7.76K ﹤0.01% 1312
2017
Q3
$22K Buy
1,022
+604
+144% +$13K ﹤0.01% 1213
2017
Q2
$9K Buy
+418
New +$8.39K ﹤0.01% 1317

Other funds holding PRPH

Acadian Asset Management's PRPH Position: Q2 2023 in Review

Acadian Asset Management sold out of ProPhase Labs (PRPH) in Q2 2023, closing a stake of 9,718 shares — an estimated $739K sold.

Acadian Asset Management first reported a position in PRPH in Q2 2017 and held it in 14 quarters. The position peaked at $1.29M in Q4 2022. 45 funds tracked by Wall St. Rank hold PRPH as of Q2 2023.

  • Acadian Asset Management reported no remaining ProPhase Labs position as of Q2 2023 after selling out during the quarter.
  • Acadian Asset Management sold 9,718 ProPhase Labs shares in Q2 2023, an estimated $739K.
  • Acadian Asset Management first reported a position in ProPhase Labs in Q2 2017 and held it in 14 quarters.
  • Acadian Asset Management's ProPhase Labs position peaked at $1.29M in Q4 2022.
  • 45 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2023.

Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.